会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明专利
    • AT320422B
    • 1975-02-10
    • AT732370
    • 1970-08-11
    • OLE NIELSENMAX BEIDIL
    • B29C51/08B29C51/22B31F1/07D21H5/24
    • 1312359 Embossing O NIELSEN and M BEIDIL 7 Aug 1970 [13 Aug 1969] 38090/70 Heading B6J A method of embossing sheet material comprises passing it through a nip between a pair of complementary rollers, each roller having a plurality of projections 40, Fig. 3, each of generally frusto-pyramidal configuration with a four sided base, extending outwardly therefrom and each projection of each roller engaging, in the nip, between projections of the other roller, and wherein each projection has one pair of opposite corners thereof aligned parallel to the axes of the rollers. The projections may be of convex cross-section, Fig. 5. The upper roller may be arranged in vertically slidable bearings 12 and 13 and the rollers may be driven from a motor 11 through sprockets 8 and 10 and chain 9. A gear 5 transmits the drive to the upper roller through a gear 6 which is in two sections to permit adjustment for elimination of play.
    • 4. 发明申请
    • CRYSTALLINE BASE OF ESCITALOPRAM AND ORODISPERSIBLE TABLETS COMPRISING ESCITALOPRAM BASE
    • 包括ESCITALOPRAM基板的晶圆和可折叠片
    • US20110046218A1
    • 2011-02-24
    • US12916750
    • 2010-11-01
    • Robert DancerHans PetersenOle NielsenMichael Harold RockHelle EliasenKen Liljegren
    • Robert DancerHans PetersenOle NielsenMichael Harold RockHelle EliasenKen Liljegren
    • A61K31/343C07D307/87A61P25/24
    • C07D307/81
    • The present invention relates to the crystalline base of the well known antidepressant drug escitalopram, S-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, formulations of said base, a process for the preparation of purified salts of escitalopram, such as the oxalate, using the base, the salts obtained by said process and formulations containing such salts, and a process for the preparation of purified escitalopram free base or salts of escitalopram, such as the oxalate, using the hydrobromide, the salts obtained by said process and formulations containing such salts. Finally the present invention relates to an orodispersible tablet having a hardness of at least 22 N and an oral-disintegration time of less than 120 s and comprising an active pharmaceutical ingredient adsorbed onto a water soluble filler wherein the active pharmaceutical ingredient has a melting point in the range of 40-100° C., as well as a method for making such an orodispersible tablet.
    • 本发明涉及众所周知的抗抑郁药物依他普仑S-1- [3-(二甲基氨基)丙基] -1-(4-氟苯基)-1,3-二氢-5-异苯并呋喃甲腈的结晶碱,所述制剂为 碱,使用碱,草酸盐的纯化盐的制备方法,通过所述方法获得的盐和含有这些盐的制剂的方法,以及制备纯化的依他普仑游离碱或依他普仑的盐的方法, 例如草酸盐,使用氢溴酸盐,通过所述方法获得的盐和含有这些盐的制剂。 最后,本发明涉及硬度至少为22N,口服崩解时间小于120秒的可分散片剂,其包含吸附在水溶性填料上的活性药物成分,其中活性药物成分的熔点为 40-100℃的范围,以及制造这种可分散片剂的方法。
    • 5. 发明授权
    • Ostomy appliance with multiple openings for preventing filter input blockage
    • 具有多个开口的造口术器具可防止过滤器输入堵塞
    • US07367965B2
    • 2008-05-06
    • US10499823
    • 2003-02-26
    • Lars Bo PoulsenPer Ole Nielsen
    • Lars Bo PoulsenPer Ole Nielsen
    • A61M1/00A61F5/44
    • A61F5/441
    • An ostomy appliance with a front wall and a rear wall of flexible material forming a bag, the rear wall having an opening into the bag by which waste material can enter the bag. The bag has two or more vents through which gas may escape from the bag and a filter device covering each vent. Each filter device has gas inlet and outlet openings in communication with a respective filter body so that in use gas flows through the filter device from the inlet opening through the filter body to the outlet opening. The inlet openings communicate with the inner space of the bag and are located near the border of the bag, being spaced at an angle of at least 45 degrees along radii of a circle of reference having a perimeter concentric with the waste opening of the bag.
    • 一种具有形成袋的柔性材料的前壁和后壁的造口术器具,所述后壁具有通过所述袋的开口,废料可以通过该开口进入袋中。 该袋具有两个或更多个通风口,气体可以从该通气口从袋中逸出,并且覆盖每个排气口的过滤装置。 每个过滤装置具有与相应的过滤器主体连通的气体入口和出口,使得在使用中气体通过过滤器装置从入口通过过滤器主体流到出口。 入口开口与袋的内部空间连通并且位于袋的边界附近,沿着具有与袋的废物开口同心的周边的参考圆的半径以至少45度的角度间隔开。
    • 6. 发明申请
    • CRYSTALLINE BASE OF ESCITALOPRAM AND ORODISPERSIBLE TABLETS COMPRISING ESCITALOPRAM BASE
    • 包括ESCITALOPRAM基板的晶圆和可折叠片
    • US20070021499A1
    • 2007-01-25
    • US11425522
    • 2006-06-21
    • Robert DancerHans PetersenOle NielsenMichael RockHelle EliasenKen Liljegren
    • Robert DancerHans PetersenOle NielsenMichael RockHelle EliasenKen Liljegren
    • A61K31/343C07D307/02
    • C07D307/81
    • The present invention relates to the crystalline base of the well known antidepressant drug escitalopram, S-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, formulations of said base, a process for the preparation of purified salts of escitalopram, such as the oxalate, using the base, the salts obtained by said process and formulations containing such salts, and a process for the preparation of purified escitalopram free base or salts of escitalopram, such as the oxalate, using the hydrobromide, the salts obtained by said process and formulations containing such salts. Finally the present invention relates to an orodispersible tablet having a hardness of at least 22 N and an oral-disintegration time of less than 120 s and comprising an active pharmaceutical ingredient adsorbed onto a water soluble filler wherein the active pharmaceutical ingredient has a melting point in the range of 40-100° C., as well as a method for making such an orodispersible tablet.
    • 本发明涉及众所周知的抗抑郁药物依他普仑S-1- [3-(二甲基氨基)丙基] -1-(4-氟苯基)-1,3-二氢-5-异苯并呋喃甲腈的结晶碱,所述制剂为 碱,使用碱,草酸盐的纯化盐的制备方法,通过所述方法获得的盐和含有这些盐的制剂的方法,以及制备纯化的依他普仑游离碱或依他普仑的盐的方法, 例如草酸盐,使用氢溴酸盐,通过所述方法获得的盐和含有这些盐的制剂。 最后,本发明涉及硬度至少为22N,口服崩解时间小于120秒的可分散片剂,其包含吸附在水溶性填料上的活性药物成分,其中活性药物成分的熔点为 40-100℃的范围,以及制造这种可分散片剂的方法。